JP2005506324A - 抗炎症剤としてのアミノピロール化合物 - Google Patents

抗炎症剤としてのアミノピロール化合物 Download PDF

Info

Publication number
JP2005506324A
JP2005506324A JP2003524985A JP2003524985A JP2005506324A JP 2005506324 A JP2005506324 A JP 2005506324A JP 2003524985 A JP2003524985 A JP 2003524985A JP 2003524985 A JP2003524985 A JP 2003524985A JP 2005506324 A JP2005506324 A JP 2005506324A
Authority
JP
Japan
Prior art keywords
disease
formula
compound
phenyl
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003524985A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005506324A5 (https=
Inventor
ゴールドスタイン,デービッド・マイケル
ロートスタイン,デービッド・マーク
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of JP2005506324A publication Critical patent/JP2005506324A/ja
Publication of JP2005506324A5 publication Critical patent/JP2005506324A5/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2003524985A 2001-08-30 2002-08-26 抗炎症剤としてのアミノピロール化合物 Pending JP2005506324A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31616901P 2001-08-30 2001-08-30
PCT/EP2002/009505 WO2003020715A1 (en) 2001-08-30 2002-08-26 Aminopyrrole compounds as antiinflammatory agents

Publications (2)

Publication Number Publication Date
JP2005506324A true JP2005506324A (ja) 2005-03-03
JP2005506324A5 JP2005506324A5 (https=) 2005-11-17

Family

ID=23227809

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003524985A Pending JP2005506324A (ja) 2001-08-30 2002-08-26 抗炎症剤としてのアミノピロール化合物

Country Status (16)

Country Link
US (1) US6696471B2 (https=)
EP (1) EP1423378B1 (https=)
JP (1) JP2005506324A (https=)
KR (1) KR20040029075A (https=)
CN (1) CN1281603C (https=)
AR (1) AR037140A1 (https=)
AT (1) ATE309239T1 (https=)
AU (1) AU2002331179B2 (https=)
BR (1) BR0212077A (https=)
CA (1) CA2458808A1 (https=)
DE (1) DE60207273T2 (https=)
ES (1) ES2252509T3 (https=)
MX (1) MXPA04001810A (https=)
PL (1) PL373115A1 (https=)
RU (1) RU2315045C2 (https=)
WO (1) WO2003020715A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2181704B1 (en) 2002-12-30 2015-05-06 Angiotech International Ag Drug delivery from rapid gelling polymer composition
US20080113016A1 (en) * 2004-07-26 2008-05-15 Gary Steven Firestein Method for Prevention or Treatment of Inflammatory Disease
CA2681420A1 (en) * 2007-03-20 2008-09-25 Cadila Pharmaceuticals Limited P38 inhibitors
WO2017075274A1 (en) 2015-10-27 2017-05-04 Children's Hospital Medical Center Use of mapk inhibitors to reduce loss of hematopoietic stem cells during ex vivo culture and/or genetic manipulation
WO2017151409A1 (en) 2016-02-29 2017-09-08 University Of Florida Research Foundation, Incorporated Chemotherapeutic methods
US10342786B2 (en) 2017-10-05 2019-07-09 Fulcrum Therapeutics, Inc. P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
WO2019071147A1 (en) 2017-10-05 2019-04-11 Fulcrum Therapeutics, Inc. INHIBITORS OF KINASE P38 REDUCING EXPRESSION OF DUX4 GENE AND DOWNSTREAM GENES FOR THE TREATMENT OF FSHD

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5068234A (en) * 1990-02-26 1991-11-26 Sterling Drug Inc. 3-arylcarbonyl-1-(c-attached-n-heteryl)-1h-indoles
BR9710352A (pt) 1996-07-11 1999-08-17 Pfizer Compostos piridilpirrole
WO1998007425A1 (en) * 1996-08-21 1998-02-26 Smithkline Beecham Corporation Imidazole compounds, compositions and use
US5776954A (en) * 1996-10-30 1998-07-07 Merck & Co., Inc. Substituted pyridyl pyrroles, compositions containing such compounds and methods of use
CA2329065A1 (en) 1998-05-05 1999-11-11 Francisco Xavier Talamas Pyrazole derivatives as p-38 map kinase inhibitors
WO1999058523A1 (en) * 1998-05-14 1999-11-18 G.D. Searle & Co. 1,5-DIARYL SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS

Also Published As

Publication number Publication date
CN1547578A (zh) 2004-11-17
MXPA04001810A (es) 2004-07-08
PL373115A1 (en) 2005-08-08
US6696471B2 (en) 2004-02-24
ES2252509T3 (es) 2006-05-16
KR20040029075A (ko) 2004-04-03
DE60207273D1 (de) 2005-12-15
EP1423378A1 (en) 2004-06-02
DE60207273T2 (de) 2006-07-20
AR037140A1 (es) 2004-10-27
AU2002331179B2 (en) 2008-04-17
CA2458808A1 (en) 2003-03-13
EP1423378B1 (en) 2005-11-09
US20030130319A1 (en) 2003-07-10
BR0212077A (pt) 2004-09-28
WO2003020715A1 (en) 2003-03-13
RU2315045C2 (ru) 2008-01-20
ATE309239T1 (de) 2005-11-15
CN1281603C (zh) 2006-10-25
RU2004109817A (ru) 2005-10-20

Similar Documents

Publication Publication Date Title
FI88504B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 4-benzyl-1-(2h)-ftalazinonderivat
KR900006853B1 (ko) 약리학적으로 활성인 피라졸로/4,3-c/피리딘의 제조방법
JPH02270874A (ja) アザビシクロ化合物及びそれらの塩、それらの製造方法、それらを含有する製薬組成物並びにそれらの薬剤としての使用
JPH0647589B2 (ja) キヌクリジン誘導体及びその組成物
HUT74090A (en) Indole derivatives, process for producing them and pharmaceutical compositions containing them
KR20110057157A (ko) 비만세포 트립타제의 억제제로서 [4-(5-아미노메틸-2-플루오로-페닐)-피페리딘-1-일]-[7-플루오로-1-(2-메톡시-에틸)-4-트리플루오로메톡시-1h-인돌-3-일]-메타논
JP4740116B2 (ja) 精神疾患および神経障害の処置のための5−ht受容体アンタゴニスト
JPS58219161A (ja) 1,3−ジヒドロ−4−(1−ヒドロキシ−2−アミノエチル)−2h−インド−ル−2−オンの新誘導体、それらの塩類、それらの製造法、薬剤としての使用及びこれらを含有する組成物
JP3057095B2 (ja) イサチン誘導体、その製造方法及びその使用方法
JP2005506324A (ja) 抗炎症剤としてのアミノピロール化合物
JPH05140108A (ja) ピリジニルピペラジン誘導体
JPS5824581A (ja) 2―オキソピリド―3―イル又はピペリジン―3―イルインドールの新誘導体及びそれらの塩、これらの製造法並びにそれらを含有する薬剤組成物
JPH02178263A (ja) アザアズレン誘導体、その製造法およびそれを有効成分とする抗アレルギー剤および抗炎症剤
JP2588977B2 (ja) ベンゼン誘導体、その調製およびこれを含有する薬学的組成物
JP3171261B2 (ja) 神経弛緩薬等としてのn−置換された3−アザビシクロ[3.2.0]ヘプタン誘導体
AU2002331179A1 (en) Aminopyrrole compounds as antiinflammatory agents
JP2726999B2 (ja) イミダゾ[2,1−b]ベンゾチアゾール誘導体及び該化合物を有効成分とする抗潰瘍剤
JP3694774B2 (ja) フェニルカルボン酸誘導体
JPH03163042A (ja) カルコン誘導体
HU198296B (en) Process for producing new 2-pyridyl acetic acid derivatives and pharmaceutical compositions comprising same
EP0058009A1 (en) Novel benzanilide derivatives and pharmaceutical compositions containing them
JPS625423B2 (https=)
JPH0688999B2 (ja) ピロロ〔3,2―e〕ピラゾロ〔1,5―a〕ピリミジン誘導体およびこれを含有する医薬
JP3709203B2 (ja) 5−ht1aレセプターに対して親和性をもつ三環式化合物
JP2009519279A (ja) 三員環ラクタム誘導体、それらの製造方法、及び医薬剤としての使用

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050805

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20090204

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090210

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20090630